ESG
Breast cancer patients to benefit from elective surgery resumption
Breast Cancer Network Australia (BCNA) welcomes the lift in the COVID-19 restrictions on some elective surgeries. The news will see post-cancer breast reconstruction and IVF start again as early as Monday.
Breast Reconstruction
Some breast cancer patients who have been scheduled for a mastectomy during this time have been unable to have an immediate breast reconstruction.
BCNA CEO Kirsten Pilatti says, we are delighted Minister Hunt has announced that reconstruction can now be provided. If a woman wants a breast reconstruction following a mastectomy, then she should be able to have one.
“We are very happy to hear the elective surgery restrictions have been lifted for breast reconstruction. One of the challenges is that breast reconstruction should never be considered an elective surgery. It is just so important that we ensure that, if there is capacity, we resume these reconstructions so they can rebuild their lives.”
BCNA knows that jurisdictions may currently be in different circumstances, depending on the extent of COVID-19 in local areas, or their waiting lists, however it’s important that all Australian women and men diagnosed with breast cancer continue to receive the best care, which includes the option to have a breast reconstruction.
IVF
Women aged 20-39 account for around 5% of all breast cancer diagnoses in Australia and some treatments, especially chemotherapy, are known to reduce fertility.
BCNA CEO Kirsten Pilatti says, there is often only a small window for patients to undergo fertility treatment before starting chemotherapy.
“Lifting the IVF restrictions will be a huge relief for so many young women who have been newly diagnosed with breast cancer as it means they can undergo fertility preservation and keep their options open for the future.”
It is now more important than ever that young women have access to information about fertility preservation when diagnosed. BCNA has a fertility resource available on our My Journey online tool to help women make decisions.
News & Trends - Pharmaceuticals
Roche’s immunotherapy drug shows promising results for Australian patients with rare blood cancer
Pharma News: Roche’s immunotherapy drug has shown high response rates in patients with a rare form of blood cancer that […]
MoreNews & Trends - Pharmaceuticals
Government seals deal with industry for rare cancer therapy
Pharma News: Australian children and young adults diagnosed with high-risk neuroblastoma will continue to receive free access to a promising, […]
MoreNews & Trends - MedTech & Diagnostics
Abbott showcases leadless pacemaker system to local stakeholders
MedTech & Diagnostics News: Leadless pacemakers are promising alternatives to transvenous pacing. Abbott hosted a stakeholder event at the recent […]
MoreNews & Trends - Pharmaceuticals
Australian scientists pivotal in new drug class from BMS
Pharma News: The first new class of drug for schizophrenia in decades has been approved, offering a fresh approach by […]
More